Surgalign Holdings, Inc. Common Stock
SRGA
SRGA was delisted on the 30th of June, 2023.
36 hedge funds and large institutions have $3.89M invested in Surgalign Holdings, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 2 closing their positions.
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
33% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 6
9% more capital invested
Capital invested by funds: $3.58M → $3.89M (+$306K)
3% more funds holding
Funds holding: 35 → 36 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$1.07M |
| 2 |
Verition Fund Management
Greenwich,
Connecticut
|
+$80.3K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$70.4K |
| 4 |
AWS
Atria Wealth Solutions
New York
|
+$65.6K |
| 5 |
VF
Virtu Financial
New York
|
+$28.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$54.4K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2.72K |
| 3 |
GTAM
Global Trust Asset Management
West Palm Beach,
Florida
|
-$2.37K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$1.56K |
| 5 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
-$988 |
SRGA Hedge Fund Activity: Q1 2023 in Review
36 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Surgalign Holdings, Inc. Common Stock (SRGA) for Q1 2023, worth a combined $3.89M — up 8.5% from $3.58M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new SRGA positions and 2 closed out — a net gain of 1 holder — while 8 added to existing stakes and 6 trimmed.
The largest buyer was Armistice Capital, adding an estimated $1.07M. The largest seller was Jane Street, cutting an estimated $54.4K.
- 36 institutional investors held Surgalign Holdings, Inc. Common Stock (SRGA) as of Q1 2023, up from 35 in Q4 2022.
- Funds reported $3.89M of Surgalign Holdings, Inc. Common Stock stock for Q1 2023, up 8.5% quarter-over-quarter.
- 3 funds opened new Surgalign Holdings, Inc. Common Stock positions in Q1 2023 and 2 closed out, a net change of +1 holder.
- The largest Surgalign Holdings, Inc. Common Stock buyer in Q1 2023 was Armistice Capital, an estimated $1.07M added.
- The largest Surgalign Holdings, Inc. Common Stock seller in Q1 2023 was Jane Street, an estimated $54.4K sold.
Based on aggregated 13F filings for Q1 2023.